Author

Bruno Nervi

Profesor Asociado, Pontificia Universidad Cat

Biography

Bruno Nervi is currently working as a Professor in the Department of Hematology and Oncology. His research interests includes Medicine. He is serving as an editorial member and reviewer of several international reputed journals. He has successfully completed his Administrative responsibilities. He has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Biliary tract cancer
JW Valle, RK Kelley, B Nervi, DY Oh, AX ZhuThe Lancet 397 (10272), 428-444, 2021202
334
2021
Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up
F Salech, S Valderrama, B Nervi, JC Rodriguez, D Oksenberg, A Koch, ...Annals of hepatology 10 (1), 99-102, 2016201
77
2016
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial
ME Balcells, L Rojas, N Le Corre, C Martínez-Valdebenito, ME Ceballos, ...PLoS medicine 18 (3), e1003415, 2021202
75
2021
Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis
ZJ Ward, M Walbaum, B Walbaum, MJ Guzman, JJ de la Jara, B Nervi, ...The Lancet Oncology 22 (10), 1427-1437, 2021202
57
2021
The CCL2/CCR2 axis affects transmigration and proliferation but not resistance to chemotherapy of acute myeloid leukemia cells
P Macanas-Pirard, T Quezada, L Navarrete, R Broekhuizen, A Leisewitz, ...PloS one 12 (1), e0168888, 2017201
41
2017
Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates …
P Macanas-Pirard, R Broekhuizen, A González, C Oyanadel, D Ernst, ...Oncotarget 8 (14), 23073, 2017201
39
2017
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a …
RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ...The Lancet 401 (10391), 1853-1865, 202
23
2023
Early anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: a randomized phase II clinical trial
ME Balcells, L Rojas, N Le Corre, C Martínez-Valdebenito, ME Ceballos, ...medRxiv, 2020.09. 17.20196212, 2020202
22
2020
High proportion of potential candidates for immunotherapy in a chilean cohort of gastric cancer patients: Results of the FORCE1 study
M Cordova-Delgado, MP Pinto, IN Retamal, M Muñoz-Medel, ML Bravo, ...Cancers 11 (9), 1275, 2019201
21
2019
Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients
GI Owen, MP Pinto, IN Retamal, MF Fernádez, B Cisternas, S Mondaca, ...Medicine 97 (16), 2018201
21
2018
Hippo-YAP1 is a prognosis marker and potentially targetable pathway in advanced gallbladder cancer
P García, L Rosa, S Vargas, H Weber, JA Espinoza, F Suárez, ...Cancers 12 (4), 778, 2020202
19
2020
Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile
ME Balcells, N Le Corre, J Durán, ME Ceballos, C Vizcaya, S Mondaca, ...Clinical Infectious Diseases: An Official Publication of the Infectious …, 2022202
18
2022
A molecular stratification of chilean gastric cancer patients with potential clinical applicability
MP Pinto, M Córdova-Delgado, IN Retamal, M Muñoz-Medel, ML Bravo, ...Cancers 12 (7), 1863, 2020202
16
2020
Metformin protects from oxaliplatin induced peripheral neuropathy in rats
NW Martinez, A Sánchez, P Diaz, R Broekhuizen, J Godoy, S Mondaca, ...Neurobiology of Pain 8, 100048, 2020202
14
2020
Evaluation and management of incidental gallbladder cancer
MY Zaidi, GK Abou-Alfa, CG Ethun, SV Shrikhande, M Goel, B Nervi, ...Chinese clinical oncology 8 (4), 37, 2019201
14
2019
Chilean registry for neuroendocrine tumors: A Latin American perspective
MP Pinto, M Muñoz Medel, D Carrillo, IN Retamal, ML Bravo, ...Hormones and Cancer 10, 3-10, 2019201
13
2019
Biliary tract cancer prognostic and predictive genomics
S Mondaca, B Nervi, M Pinto, GK Abou-AlfaChinese clinical oncology 8 (4), 42, 2019201
11
2019
Reduced immune response to inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a cohort of immunocompromised patients in Chile
ME Balcells, N Le Corre, J Durán, ME Ceballos, C Vizcaya, S Mondaca, ...Clinical Infectious Diseases 75 (1), e54-e602, 2022202
9
2022
Mortality of adult patients with cancer admitted to an intensive care unit in Chile: A prospective cohort study
S Panay, C Ruiz, M Abarca, B Nervi, I Salazar, P Caro, S Muñiz, J Briones, ...Journal of global oncology 4, 1-, 2018201
9
2018
SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study
M Dib, N Le Corre, C Ortiz, D García, M Ferrés, C Martinez-Valdebenito, ...The Lancet Regional Health–Americas 16, 2022202
7
2022

Referred From: https://scholar.google.com/citations?hl=en&user=uqj_5YsAAAAJ

Cited by
Citations 2621
h-index 21
i10-index 39
Recommended Journals
Open Access Journals